Targeting of the tumor microenvironment (TME) is recognized as a promising area in oncology drug development due to the critical role of the TME, including tumor cells, stromal features, nuclear features, immune cells, tertiary lymphoid structures, and other important features, in regulating disease progression and therapeutic response. |
